Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cellsThe European ISHAGE Working Group for Standardization of Tumor Cell Detection
References (17)
- et al.
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
Lancet
(1996) - et al.
An immuno-logical enrichment method for epithelial cells from peripheral blood
J Immunol Methods
(1995) - et al.
Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
J Hematother
(1994) - et al.
Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
J Pathol
(1998) - et al.
Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
J Natl Cancer Inst
(1998) - et al.
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
J Clin Oncol
(1991) - et al.
Detection of occult bone marrow micrometastases in patients with operable lung carcinoma
Ann Surg
(1995) - et al.
Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
J Clin Oncol
(1998)
There are more references available in the full text version of this article.
Cited by (270)
Biomarkers of minimal residual disease and treatment
2024, Advances in Clinical ChemistryDisseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
2021, European Journal of CancerDetermination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients
2024, Archives of Gynecology and Obstetrics
Copyright © 1999 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.